A pilot study on the effects of in-feed probiotic Lactobacillus rhamnosus ATCC 53103 (LGG) on vaccinated Atlantic salmon ( Salmo salar ): microbiomes and Aeromonas salmonicida challenge resilience
Canadian Journal of Microbiology · 2025
DOI: 10.1139/cjm-2024-0130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Microbiology, 2025. Verfasst von Natalia Lorenc und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Agricultural and Environmental Sciences, McGill University, Montreal, QC H9X 3V9, Canada. Hauptthemen laut MEDLINE: Probiotics, Salmo salar, Lacticaseibacillus rhamnosus, Aeromonas salmonicida. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Genomics Research and Development Initiative, project GRDI-AMR-One-Health.
Abstract (Originalsprache)
The use of probiotics is an alternative approach to mitigate the proliferation of antimicrobial resistance in aquaculture. In our study, we examined the effects of Lactobacillus rhamnosus GG (ATCC 53103, LGG) delivered in-feed on the weight, length, skin mucus, and faecal microbiomes of Atlantic salmon. We also challenged the salmon with Aeromonas salmonicida 2004-05MF26 (Asal2004) and assessed the mortality. Our results showed no significant change ( P > 0.05) in weight or length of Atlantic salmon or their resilience to Asal2004 infection after LGG feeding. Infection changed significantly the skin mucus and faecal microbiomes: Clostridium sensu stricto increased from 3.14% to 9.20% in skin mucus and 1.39% to 3.74% in faeces ( P < 0.05). Aeromonas increased from 0.02% to 0.60% in faeces ( P < 0.05). Photobacterium increased from not detected (0%) to 52.16% ( P < 0.01) and Aliivibrio decreased from 67.21% to 0.71% in faeces ( P < 0.01). After infection, Lactococcus (9.93%) and Lactobacillus (2.11%) in skin mucus of the LGG group were significantly higher ( P < 0.05) than in the skin mucus from the rest of the groups (4.14% and 1.08%, respectively). In conclusion, LGG feeding did not further increase the resilience of vaccinated Atlantic salmon. Asal2004 infection had much greater impact on skin mucus and faecal microbiomes than LGG feeding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Agricultural and Environmental Sciences, McGill University, Montreal, QC H9X 3V9, Canada.
- Fisheries and Oceans Canada, St. Andrews Biological Station, Saint Andrews, NB E5B 0E4, Canada.
- Faculty of Science, McGill University, Montreal, QC H3A 0G4, Canada.
- Agriculture and Agri-Food Canada, Lacombe Research and Development Centre, Lacombe, AB T4L 1W1, Canada.
ORCID-Profile: Josh Wang, Xiaoji Liu
Förderung
- Genomics Research and Development Initiative, project GRDI-AMR-One-Health
Zitieren
APA
Lorenc, N., Leadbeater, S., Wang, J., Ronholm, J., & Liu, X. (2025). A pilot study on the effects of in-feed probiotic Lactobacillus rhamnosus ATCC 53103 (LGG) on vaccinated Atlantic salmon ( Salmo salar ): microbiomes and Aeromonas salmonicida challenge resilience. Canadian Journal of Microbiology. https://doi.org/10.1139/cjm-2024-0130
Vancouver
Lorenc N, Leadbeater S, Wang J, Ronholm J, Liu X. A pilot study on the effects of in-feed probiotic Lactobacillus rhamnosus ATCC 53103 (LGG) on vaccinated Atlantic salmon ( Salmo salar ): microbiomes and Aeromonas salmonicida challenge resilience. Canadian Journal of Microbiology. 2025. doi:10.1139/cjm-2024-0130
BibTeX
@article{Lorenc2025,
author = {Lorenc, Natalia and Leadbeater, Steven and Wang, Josh and Ronholm, Jennifer and Liu, Xiaoji},
title = {A pilot study on the effects of in-feed probiotic Lactobacillus rhamnosus ATCC 53103 (LGG) on vaccinated Atlantic salmon ( Salmo salar ): microbiomes and Aeromonas salmonicida challenge resilience},
journal = {Canadian Journal of Microbiology},
year = {2025},
doi = {10.1139/cjm-2024-0130}
}
EUVIMED